11^th International Conference on Interventional Cardiology October 24-25, 2024 Zurich, Switzerland

The 11th International Conference on Interventional Cardiology, scheduled to take place on October 24-25, 2024, in the picturesque city of Zurich, Switzerland. This conference will serve as a premier platform for leading cardiologists, cardiovascular surgeons, researchers, and industry professionals to gather and exchange knowledge on the latest advancements in cardiovascular interventions.

The theme for Interventional Cardiology 2024 conference is "Advancements in Cardiovascular Interventions: Diagnosis to Regeneration." We aim to delve into the spectrum of innovative techniques, technologies, and strategies that span the entire continuum of cardiovascular care, from early diagnosis to the exciting frontier of regenerative therapies.

Join us in Zurich for an enriching and transformative experience at the forefront of cardiovascular interventions. Together, let's explore new horizons in cardiovascular care and pave the way towards improved patient outcomes and enhanced quality of life. We look forward to welcoming you to the 11th International Conference on Interventional Cardiology.

Tracks1.Innovations in Structural Heart Interventions:

• Transcatheter Aortic Valve Replacement (TAVR) and Mitral Valve Repair: Advances and Outcomes
• Emerging Techniques in Left Atrial Appendage Closure
• Percutaneous Treatment of Structural Heart Defects: Beyond the Basics

Tracks2.Advancements in Coronary Interventions:

• Next-Generation Drug-Eluting Stents: Efficacy and Safety Profiles
• Intravascular Imaging Modalities: Optimizing Guidance for Complex Interventions
• Physiology-Guided PCI: From FFR to iFR and Beyond

Tracks3.Electrophysiology and Arrhythmia Management:

• Catheter Ablation Strategies for Atrial Fibrillation: Mapping, Ablation, and Outcome Predictors
• Device Therapy for Heart Failure: Current Status and Future Directions
• Advances in Leadless Pacemaker Technology and Subcutaneous ICDs

Tracks4.Diagnostic Modalities in Interventional Cardiology:

• Multimodality Imaging in the Assessment of Ischemic Heart Disease
• Role of Artificial Intelligence and Machine Learning in Cardiac Imaging Interpretation
• Non-Invasive Assessment of Coronary Artery Disease: Stress Testing and CT Angiography

Track5.Regenerative Therapies and Novel Approaches:

• Stem Cell Therapy for Ischemic Heart Disease: Clinical Trials and Future Perspectives
• Gene Therapy and Cardiovascular Regeneration: Promises and Challenges
• Tissue Engineering Strategies for Myocardial Repair and Regeneration

Tracks6.Challenges and Controversies in Interventional Cardiology:

• Dual Antiplatelet Therapy (DAPT) Duration: Balancing Ischemic and Bleeding Risks
• Optimal Antithrombotic Regimens in Patients with Atrial Fibrillation Undergoing PCI
• Complex PCI: Managing Calcified Lesions, Chronic Total Occlusions, and Bifurcation Disease

Track7.Lifestyle and Preventive Cardiology:

• Nutrition and Exercise Interventions for Cardiovascular Health
• Smoking Cessation Strategies: Impact on Cardiovascular Risk Reduction
• Psychosocial Factors and Stress Management in Coronary Artery Disease

Track8.Healthcare Delivery and Quality Improvement:

• Integrating Telemedicine and Remote Monitoring in Cardiovascular Care
• Enhancing Multidisciplinary Collaboration in Heart Teams: Case-Based Discussions
• Strategies for Reducing Disparities in Access to High-Quality Cardiovascular Care

Track9.Innovations in Transcatheter Valve Therapies:

• Advances in Transcatheter Aortic Valve Replacement (TAVR)
• Mitral Valve Interventions: From Repair to Replacement
• Novel Approaches in Tricuspid Valve Repair

Track10.Emerging Techniques in Coronary Interventions:

• Bioresorbable Vascular Scaffolds: Current Status and Future Directions
• Intravascular Lithotripsy for Calcified Coronary Lesions
• Robotic-Assisted Percutaneous Coronary Intervention (PCI)

Track11.Structural Heart Disease: Beyond Valve Interventions:

• Left Atrial Appendage Occlusion: Device Selection and Procedural Considerations
• Interventions for Congenital Heart Defects in Adults
• Percutaneous Treatment of Hypertrophic Cardiomyopathy

Track12.Electrophysiology Advances:

• Catheter Ablation for Ventricular Arrhythmias: Mapping and Ablation Strategies
• Cardiac Resynchronization Therapy: Optimization and Patient Selection
• Wearable Cardioverter-Defibrillator Therapy: Indications and Outcomes

Track13.Imaging Modalities in Interventional Cardiology:

• Intravascular Imaging Techniques: OCT, IVUS, and NIRS
• Cardiac MRI in Guiding Structural Heart Interventions
• 3D Echocardiography for Procedural Planning and Guidance

Track14.Precision Medicine in Interventional Cardiology:

• Genomic Profiling in Cardiovascular Disease: Implications for Personalized Therapy
• Pharmacogenomics in Antiplatelet and Anticoagulant Therapy
• Biomarker-Guided Risk Stratification in Acute Coronary Syndromes

Track15.Advanced Heart Failure Interventions:

• Left Ventricular Assist Devices: Patient Selection and Management Strategies
• Novel Approaches in Heart Transplantation
  Percutaneous Mechanical Circulatory Support Devices: Indications and Outcomes

Track16.Emerging Therapies for Myocardial Regeneration:

• Cell-Based Therapies for Heart Failure: Clinical Trials and Challenges
• Biomaterials and Tissue Engineering for Cardiac Repair
• Gene Editing Technologies for Cardiovascular Disease

Track17.Innovations in Peripheral Vascular Interventions:

• Endovascular Therapy for Peripheral Artery Disease
• Renal Denervation for Resistant Hypertension
• Emerging Techniques in Venous Interventions

Track18.Quality Improvement and Patient Safety:

• Risk Reduction Strategies in Catheterization Laboratories
• Enhancing Procedural Outcomes through Team Training and Simulation
• Utilization of Registries and Quality Metrics in Cardiovascular Care

Cardiologists:
Interventional cardiologists
Clinical cardiologists
Pediatric cardiologists
Electrophysiologists

Cardiovascular Surgeons:
Interventional cardiovascular surgeons
Thoracic surgeons
Pediatric cardiac surgeons

Cardiovascular Researchers:
Academic researchers in cardiovascular medicine
Clinical trial investigators
Translational researchers

Nurses and Allied Health Professionals:
Catheterization laboratory nurses
Cardiovascular technologists
Nurse practitioners specializing in cardiology

Medical Students and Residents:
Medical students interested in cardiology
Cardiology residents
Fellows in interventional cardiology and related specialties

Industry Professionals:
Representatives from pharmaceutical companies
Medical device manufacturers
Healthcare technology companies

Regulatory Authorities and Policy Makers:
Officials from regulatory agencies overseeing cardiovascular interventions
Policymakers involved in healthcare quality improvement and patient safety initiatives

Hospital Administrators and Healthcare Executives:
Directors of cardiology departments
Hospital administrators responsible for cardiovascular services
Healthcare executives involved in strategic planning for cardiovascular care

Patient Advocates and Support Groups:
Representatives from patient advocacy organizations focused on cardiovascular health
Support group leaders for patients with heart disease and their families

International Delegates:
Cardiologists, surgeons, and researchers from around the world interested in advancing cardiovascular interventions and patient care.

Stay Updated on Advancements: Attendees will have the opportunity to stay abreast of the latest advancements in interventional cardiology, including new techniques, technologies, and therapies shaping the field.

Learn from Experts: Engage with leading experts and thought leaders in interventional cardiology through keynote lectures, panel discussions, and interactive sessions. Benefit from their insights, experiences, and perspectives on key issues and emerging trends.

Enhance Clinical Practice: Gain practical knowledge and skills that can be directly applied to clinical practice, including updates on guidelines, best practices, and procedural techniques in cardiovascular interventions.

Networking Opportunities: Connect with colleagues, collaborators, and industry professionals from around the world. Forge new partnerships, share experiences, and exchange ideas to foster collaboration and innovation in cardiovascular care.

Earn Continuing Education Credits: The conference is accredited for Continuing Medical Education (CME) and Continuing Professional Development (CPD) credits, providing attendees with the opportunity to earn valuable credits while expanding their knowledge and skills.

Access to Cutting-edge Research: Explore a diverse range of research presentations covering the latest scientific discoveries, clinical trials, and outcomes research in interventional cardiology. Stay informed about the evidence-based practices shaping patient care.

Exhibition and Product Showcase: Visit the exhibition area to discover the latest cardiovascular devices, technologies, and pharmaceuticals showcased by leading industry exhibitors. Learn about innovative products and solutions that can enhance patient care and outcomes.

Professional Development: Enhance your professional development by participating in interactive workshops, hands-on demonstrations, and case-based discussions. Gain insights into emerging topics and develop strategies for overcoming challenges encountered in daily practice.

Contribute to the Field: Share your own research findings, clinical experiences, and insights with the international community of cardiovascular professionals. Contribute to the collective knowledge base and help advance the field of interventional cardiology.

American College of Cardiology (ACC):The ACC is a leading organization dedicated to transforming cardiovascular care and improving heart health. It provides education, research, and advocacy for cardiovascular professionals worldwide.

European Society of Cardiology (ESC):The ESC is a prestigious society committed to reducing the burden of cardiovascular disease in Europe and globally. It offers a wide range of resources, guidelines, and educational programs for cardiologists and cardiovascular professionals.

Society for Cardiovascular Angiography and Interventions (SCAI):SCAI is a leading organization focused on advancing interventional cardiology through education, advocacy, and research. It offers training programs, clinical guidelines, and networking opportunities for interventional cardiologists.

Asia-Pacific Society of Interventional Cardiology (APSIC):APSIC is a regional society dedicated to promoting excellence in interventional cardiology across the Asia-Pacific region. It organizes conferences, workshops, and scientific meetings to enhance knowledge and skills in cardiovascular interventions.

Latin American Society of Interventional Cardiology (SOLACI):SOLACI is a prominent society advancing interventional cardiology in Latin America. It provides education, training, and research opportunities for cardiovascular professionals and fosters collaboration with international partners.

Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT):CVIT is a leading association promoting excellence in cardiovascular interventions and therapeutics in Japan. It organizes conferences, symposiums, and educational activities to advance the field of interventional cardiology.

Canadian Association of Interventional Cardiology (CAIC):CAIC is a professional organization representing interventional cardiologists and cardiovascular professionals in Canada. It advocates for quality care, education, and research in the field of interventional cardiology.

Pan-African Society of Cardiology (PASCAR):PASCAR is a continental society promoting cardiovascular health and prevention in Africa. While not solely focused on interventional cardiology, it plays a crucial role in addressing the burden of cardiovascular disease on the continent.

World Heart Federation (WHF):WHF is a global organization dedicated to leading the fight against heart disease and stroke worldwide. It collaborates with national and international partners to promote heart health, prevent cardiovascular disease, and improve patient outcomes.

International Society of Cardiovascular Interventions (ISCI):ISCI is an international society dedicated to promoting excellence in cardiovascular interventions through education, research, and collaboration. It brings together cardiovascular professionals from around the world to advance the field of interventional cardiology.

The Interventional Cardiology Devices Market size is estimated at USD 17.28 billion in 2024, and is expected to reach USD 22.37 billion by 2029, growing at a CAGR of 7.48% during the forecast period (2024-2029).

The COVID-19 pandemic impacted several interventional cardiology (IC) and electrophysiology (EP) operations to be performed globally. For instance, according to an article published in PLOS ONE in September 2022, during the COVID-19 pandemic, there was a reduction in percutaneous coronary intervention (PCI) volumes and higher risk-adjusted mortality. COVID-19-positive patients experienced significantly worse outcomes. Thus, the COVID-19 pandemic had an adverse impact on the market's growth in its preliminary phase. 

Although the COVID-19 pandemic significantly impacted market growth in the initial phases, with the help of government initiatives, innovation, and digital health, the market has recovered. For instance, according to an article published by Current Cardiology Reports in March 2022, remote telehealth monitoring, telehealth clinic visits, and patient education through social media were implemented and showed benefits to those at higher risk of cardiovascular events. 

Additionally, robotic PCI emerged as a promising strategy in experienced centers during the pandemic, and it facilitated procedural distancing, minimized exposure risk, and decreased PPE cost. Hence, with better access to healthcare access and the implementation of telemedicine during the pandemic, the market was expected to gain its growth pace over the forecast period.

Furthermore, the major factors for the growth of the interventional cardiology devices market include the growing prevalence of coronary artery diseases (CADs), technological advancements in interventional cardiology devices, and the growing demand for minimally invasive treatment globally. For instance, according to the British Heart Foundation's Report published in July 2022, 7.6 million people in the United Kingdom lived with heart and circulatory diseases in 2021, out of which 4 million were men and 3.6 million were women. Therefore, the increasing burden of heart disease is anticipated to boost the usage of interventional cardiology devices, in turn driving the market growth over the forecast period.

Moreover, market players are competing to launch advanced products for better treatment and have invested in research and development programs to improve their existing product lines and launch new product portfolios. For instance, in February 2022, Cardiovascular Systems, Inc. partnered with Innova Vascular, Inc. (Innova) to develop a full line of novel thrombectomy devices. Similarly, in July 2021, ORIGIN SC and ORIGIN NC, two high-performance balloons for vessel preparation, were launched by MedAlliance for patients suffering from life-threatening coronary and peripheral arterial disease. Such development is expected to drive the growth of the market over the forecast period.

Hence, as per the aforementioned factors, such as the growing prevalence of coronary artery diseases (CADs), technological advancements in interventional cardiology devices, and the growing demand for minimally invasive treatment globally, the interventional cardiology devices market is likely to grow over the forecast period. However, a stringent regulatory scenario for manufacturing interventional cardiology devices and the availability of effective first-line treatments are expected to restrain the market's growth.

First Phase abstact submission deadline:June 30th,2024
Second Phase abstact submission deadline:August 15,2024
Final Phase abstact submission deadline:September 30,2024